Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD

被引:48
作者
Duarte, Alexander G. [1 ]
Tung, Leon [1 ]
Zhang, Wei [1 ]
Hsu, En Shuo [2 ]
Kuo, Yong-Fang [2 ,3 ]
Sharma, Gulshan [1 ,3 ]
机构
[1] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Off Biostat, Galveston, TX 77555 USA
[3] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA
基金
美国医疗保健研究与质量局;
关键词
chronic obstructive pulmonary disease; COPD; peak inspiratory flow rate; dry powder inhaler; inhalation therapy; pulmonary function test; OBSTRUCTIVE PULMONARY-DISEASE; GLOBAL STRATEGY; RESISTANCE; STANDARDIZATION; PREVENTION; PREVALENCE; MANAGEMENT; DIAGNOSIS; THERAPY; RATES;
D O I
10.15326/jcopdf.6.3.2018.0163
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objectives: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL (R) device in ambulatory patients with COPD. Methods: Patients underwent PIFR measurement with In-Check DIAL (R) device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (<= 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height. Results: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 +/- 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 +/- 56.9 L/min and 263.4 +/- 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 %of the male cohort, while females < 65 inches had a suboptimal PIFR in 27.4% of the women. Conclusions: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured females. Spirometry determined FIF max was associated with PIFR based on gender and height.
引用
收藏
页码:246 / 255
页数:10
相关论文
共 25 条
[1]   Patient adherence in COPD [J].
Bourbeau, J. ;
Bartlett, S. J. .
THORAX, 2008, 63 (09) :831-838
[2]   Inhalation profiles in asthmatics and COPD patients: Reproducibility and effect of instruction [J].
Broeders, MEAC ;
Molema, J ;
Hop, WCJ ;
Folgering, HTM .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2003, 16 (02) :131-141
[3]  
Capstick TGD, 2012, EXPERT REV RESP MED, V6, P91, DOI [10.1586/ERS.11.89, 10.1586/ers.11.89]
[4]   Is inhalation rate important for a dry powder inhaler? using the In-Check Dial to identify these rates [J].
Chrystyn, H .
RESPIRATORY MEDICINE, 2003, 97 (02) :181-187
[5]   THE RELATIONSHIP BETWEEN POWDER INHALER RESISTANCE AND PEAK INSPIRATORY CONDITIONS IN HEALTHY-VOLUNTEERS - IMPLICATIONS FOR IN-VITRO TESTING [J].
CLARK, AR ;
HOLLINGWORTH, AM .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1993, 6 (02) :99-110
[6]   Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD [J].
Derom, Eric ;
Strandgarden, Kerstin ;
Schelfhout, Vanessa ;
Borgstrom, Lars ;
Pauwels, Romain .
RESPIRATORY MEDICINE, 2007, 101 (09) :1931-1941
[7]  
Dhand R, 2018, RESP CARE, V63, P833, DOI 10.4187/respcare.05715
[8]   Device selection and outcomes of aerosol therapy: Evidence-based guidelines [J].
Dolovich, MB ;
Ahrens, RC ;
Hess, DR ;
Anderson, P ;
Dhand, R ;
Rau, JL ;
Smaldone, GC ;
Guyatt, G .
CHEST, 2005, 127 (01) :335-371
[9]   Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers [J].
Ghosh, Sohini ;
Ohar, Jill A. ;
Drummond, M. Bradley .
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (06) :381-387
[10]   Inhalation device requirements for patients' inhalation maneuvers [J].
Haidl, Peter ;
Heindl, Stefan ;
Siemon, Karsten ;
Bernacka, Maria ;
Cloes, Rolf Michael .
RESPIRATORY MEDICINE, 2016, 118 :65-75